Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

12.15
Delayed Data
As of Apr 27
 -0.18 / -1.46%
Today’s Change
11.34
Today|||52-Week Range
27.02
-32.57%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close12.33
Today’s open12.35
Day’s range12.05 - 12.35
Volume827,981
Average volume (3 months)1,578,614
Market cap$754.5M
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)+41.48%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.05-0.17%
MGNXMacroGenics Inc+0.07+0.32%
HSKAHeska Corp-2.91-2.69%
CYTKCytokinetics Inc+0.10+0.59%
Data as of 04/27/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts